Hosted on MSN14m
Denali Therapeutics’ ALS therapy fails to meet primary endpoint in Phase II/III trial
The primary analysis included 186 subjects who received the therapy and 139 subjects who were given a placebo.
National Catholic Register59m
Analysis: Understanding the Vatican’s Novel Leadership Structure of a Pro-Prefect and a Nun
The unusual decision to has sparked discussion about the intersection of traditional Church hierarchy and Pope Francis’ ...